Operating Lease, Weighted Average Discount Rate, Percent of Summit Therapeutics Inc. from 31 Jan 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: pure
Description
Weighted average discount rate for operating lease calculated at point in time.
Summary
Summit Therapeutics Inc. quarterly Operating Lease, Weighted Average Discount Rate, Percent in pure history and change rate from 31 Jan 2018 to 31 Dec 2025.
  • Summit Therapeutics Inc. Operating Lease, Weighted Average Discount Rate, Percent for the quarter ending 31 Dec 2025 was 0.076, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Weighted Average Discount Rate, Percent, Quarterly (pure)
Operating Lease, Weighted Average Discount Rate, Percent, YoY Quarterly Change (%)

Summit Therapeutics Inc. Quarterly Operating Lease, Weighted Average Discount Rate, Percent (pure)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 0.076 +0.007 +10% 31 Dec 2025 10-K 23 Feb 2026 2025 FY
Q4 2024 0.069 +0.003 +4.5% 31 Dec 2024 10-K 23 Feb 2026 2025 FY
Q4 2023 0.066 +0.009 +16% 31 Dec 2023 10-K 24 Feb 2025 2024 FY
Q3 2023 0.065 +0.008 +14% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 0.065 +0.037 +132% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 0.057 +0.03 +111% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 0.057 +0.032 +128% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 0.057 30 Sep 2022 10-Q 07 Nov 2023 2023 Q3
Q2 2022 0.028 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 0.027 +0.01 +59% 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q4 2021 0.025 -0.0125 -33% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q1 2021 0.017 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q4 2020 0.0375 0 0% 31 Dec 2020 10-K/A 21 Dec 2022 2021 FY
Q4 2019 0.0375 0 0% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q4 2018 0.0375 0 0% 31 Jan 2019 8-K 29 Sep 2020 2020 Q2
Q4 2017 0.0375 31 Jan 2018 8-K 29 Sep 2020 2020 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.